ABCL Abcellera Biologics Inc

held by 1 manager in Q3 2022

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.37%	1.3 yr	—	$7M	659,750

Search